Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Filtration Integrity Testing before Sterile Filling – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Filtration Integrity Testing before Sterile Filling – V 2.0

Standard Operating Procedure for Filtration Integrity Testing before Sterile Filling


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/132/2025
Supersedes SOP/SIM/132/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To outline the procedure for conducting filtration integrity testing (FIT) prior to sterile filling operations, ensuring that the filters used for sterilizing injectable solutions maintain integrity and comply with GMP requirements.

2.

Scope

This SOP is applicable to all filters used in the sterile manufacturing of injectable products, including 0.22 µm sterilizing-grade filters utilized before aseptic filling operations.

3. Responsibilities

  • Manufacturing Officer: Perform FIT and document results.
  • Quality Assurance (QA): Review and verify integrity test results.
  • Engineering: Maintain filtration systems and calibration of instruments.
  • QC Microbiology: Evaluate microbial retention performance if required.

4. Accountability

The Head of Production is accountable for ensuring the proper execution and documentation of pre-sterile FIT as per this SOP.

5. Procedure

5.1 Types of Filter Integrity Tests

  • Bubble Point Test
  • Diffusion Test
  • Pressure Hold Test

5.2 Pre-Test Preparations

  1. Ensure all equipment is cleaned and calibrated.
  2. Use sterilized 0.22 µm hydrophilic membrane filters or appropriate type.
  3. Connect the filter assembly to the automated integrity tester.
  4. Ensure no leaks are present in the tubing or connections.

5.3 Execution of Test

  1. Wet the filter with Water for Injection (WFI) or product solution, as applicable.
  2. Select the appropriate integrity test based on product compatibility.
  3. For bubble point:
    • Apply pressure gradually.
    • Observe the pressure where continuous bubbling begins.
  4. For diffusion:
    • Apply constant pressure (e.g., 48 psi).
    • Measure gas flow in cc/min.
  5. Compare the result with manufacturer’s acceptance criteria.

5.4 Acceptance Criteria

  1. The bubble point must not be lower than the minimum specified value.
  2. Diffusion rate must fall within the validated range.
  3. If test fails, replace the filter and repeat the test.

5.5 Documentation

  1. Record all details in the Filter Integrity Test Logbook (Annexure-1).
  2. Document the filter serial number, batch number, test method, date, result, and operator initials.
  3. Attach the automated test printout (Annexure-2).

5.6 Troubleshooting

  1. If test fails:
    • Check for wetting errors or air pockets.
    • Re-wet and re-test the filter once.
  2. Replace filter if test fails again and investigate deviation.

5.7 Post-Test Activity

  1. Upon successful completion, label the filter as “Tested – Ready for Use”.
  2. Proceed to aseptic filling only after QA approval of test report.

6. Abbreviations

  • FIT: Filter Integrity Test
  • WFI: Water for Injection
  • QA: Quality Assurance
  • QC: Quality Control

7. Documents

  1. Filter Integrity Test Logbook – Annexure-1
  2. Automated Test Printout – Annexure-2
  3. Filter Replacement Log – Annexure-3

8. References

  • USP <1207> – Sterile Product Package Integrity Evaluation
  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • FDA Guidance on Sterile Drug Products Produced by Aseptic Processing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Filter Integrity Test Logbook

Date Batch No. Filter Type Serial No. Test Type Result Performed By
20/06/2025 IV-5689 0.22 µm PES FLTR-8821 Bubble Point Pass Rajesh Kumar

Annexure-2: Automated Test Printout

Attach system-generated test result print showing:

  • Filter Type
  • Operator ID
  • Date & Time
  • Pass/Fail Status

Annexure-3: Filter Replacement Log

Date Old Filter Serial No. New Filter Serial No. Reason Approved By
20/06/2025 FLTR-7798 FLTR-8821 Integrity Test Failure Sunita Reddy

Revision History

Revision Date Revision No. Details Reason Approved By
10/01/2022 1.0 Initial Issue New SOP QA Head
24/06/2025 2.0 Revised acceptance criteria and added Annexure-3 Annual Review QA Head
See also  Sterile Injectable Manufacturing: SOP for Monitoring Batch Yield during Injectable Production - V 2.0
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Elixir Department: SOP for Alarm Handling on Mixing Equipment – V 2.0
Next Post: Analytical Method Development: SOP for Dissolution Media Filtering and Degassing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version